Header Logo

Connection

JACQUELINE HIRTH to Papillomavirus Vaccines

Back to Details
This is a "connection" page, showing publications JACQUELINE HIRTH has written about Papillomavirus Vaccines.
JACQUELINE HIRTH
Connection Strength
9.850
Papillomavirus Vaccines
  1. Effect of age at initiation of the human papillomavirus vaccine on the association between race/ethnicity and completion of the vaccine series. Vaccine. 2024 Apr 19; 42(11):2827-2836.
    View in: PubMed
    Score: 0.829
  2. Human papillomavirus dose reminder preferences among parents from a diverse clinical sample: a qualitative study. Hum Vaccin Immunother. 2022 12 31; 18(1):2031697.
    View in: PubMed
    Score: 0.718
  3. Caregiver acceptance of a patient navigation program to increase human papillomavirus vaccination in pediatric clinics: a qualitative program evaluation. Hum Vaccin Immunother. 2019; 15(7-8):1585-1591.
    View in: PubMed
    Score: 0.588
  4. Variations in reason for intention not to vaccinate across time, region, and by race/ethnicity, NIS-Teen (2008-2016). Vaccine. 2019 01 21; 37(4):595-601.
    View in: PubMed
    Score: 0.576
  5. Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26?year old females in the U.S. Vaccine. 2018 Nov 29; 36(50):7682-7688.
    View in: PubMed
    Score: 0.571
  6. Achieving high HPV vaccine completion rates in a pediatric clinic population. Hum Vaccin Immunother. 2019; 15(7-8):1562-1569.
    View in: PubMed
    Score: 0.570
  7. Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature. Hum Vaccin Immunother. 2019; 15(1):146-155.
    View in: PubMed
    Score: 0.565
  8. Human papillomavirus vaccine motivators and barriers among community college students: Considerations for development of a successful vaccination program. Vaccine. 2018 02 14; 36(8):1032-1037.
    View in: PubMed
    Score: 0.544
  9. Prevalence of oral human papillomavirus by vaccination status among young adults (18-30years old). Vaccine. 2017 06 14; 35(27):3446-3451.
    View in: PubMed
    Score: 0.516
  10. Concordance of adolescent human papillomavirus vaccination parental report with provider report in the National Immunization Survey-Teen (2008-2013). Vaccine. 2016 08 17; 34(37):4415-21.
    View in: PubMed
    Score: 0.487
  11. Effect of number of human papillomavirus vaccine doses on guideline adherent cervical cytology screening among 19-26year old females. Prev Med. 2016 07; 88:134-9.
    View in: PubMed
    Score: 0.478
  12. Regional variations in HPV vaccination among 9-17 year old adolescent females from the BRFSS, 2008-2010. Hum Vaccin Immunother. 2014; 10(12):3475-83.
    View in: PubMed
    Score: 0.409
  13. Completion of the human papillomavirus (HPV) vaccine series among males with private insurance between 2006 and 2009. Vaccine. 2013 Feb 06; 31(8):1138-40.
    View in: PubMed
    Score: 0.381
  14. Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009. Cancer. 2012 Nov 15; 118(22):5623-9.
    View in: PubMed
    Score: 0.364
  15. Prevalence of Oral Human Papillomavirus Infection: Impact of Sex, Race/Ethnicity, and Vaccination Status. Clin Infect Dis. 2022 04 09; 74(7):1230-1236.
    View in: PubMed
    Score: 0.181
  16. Prevalence of Genital Human Papillomavirus by Age and Race/Ethnicity Among Males. Clin Infect Dis. 2021 11 02; 73(9):1625-1633.
    View in: PubMed
    Score: 0.176
  17. A brief educational intervention can improve nursing students' knowledge of the human papillomavirus vaccine and readiness to counsel. Hum Vaccin Immunother. 2021 07 03; 17(7):1952-1960.
    View in: PubMed
    Score: 0.167
  18. Geographical disparities in human papillomavirus herd protection. Cancer Med. 2020 07; 9(14):5272-5280.
    View in: PubMed
    Score: 0.159
  19. An educational intervention to improve attitudes regarding HPV vaccination and comfort with counseling among US medical students. Hum Vaccin Immunother. 2020 05 03; 16(5):1139-1144.
    View in: PubMed
    Score: 0.154
  20. Regional variations in human papillomavirus prevalence across time in NHANES (2003-2014). Vaccine. 2019 07 09; 37(30):4040-4046.
    View in: PubMed
    Score: 0.149
  21. HPV Vaccination Among Foreign-Born Women: Examining the National Health Interview Survey 2013-2015. Am J Prev Med. 2018 Jan; 54(1):20-27.
    View in: PubMed
    Score: 0.133
  22. Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient. J Womens Health (Larchmt). 2017 10; 26(10):1114-1122.
    View in: PubMed
    Score: 0.131
  23. Relationship between maternal experiences and adolescent HPV vaccination. Hum Vaccin Immunother. 2017 09 02; 13(9):2150-2154.
    View in: PubMed
    Score: 0.130
  24. Adherence to ACIP Recommendation for Human Papillomavirus Vaccine Among US Adolescent Girls. J Community Health. 2017 Apr; 42(2):385-389.
    View in: PubMed
    Score: 0.128
  25. US medical students' willingness to offer the HPV vaccine by vaccination status. Vaccine. 2017 03 01; 35(9):1212-1215.
    View in: PubMed
    Score: 0.126
  26. A human papillomavirus vaccination program for low-income postpartum women. Am J Obstet Gynecol. 2016 09; 215(3):318.e1-9.
    View in: PubMed
    Score: 0.118
  27. A brief educational intervention increases providers' human papillomavirus vaccine knowledge. Hum Vaccin Immunother. 2015; 11(6):1331-6.
    View in: PubMed
    Score: 0.109
  28. Comparison of HPV prevalence between HPV-vaccinated and non-vaccinated young adult women (20-26 years). Hum Vaccin Immunother. 2015; 11(10):2337-44.
    View in: PubMed
    Score: 0.109
  29. Age at HPV vaccine initiation and completion among US adolescent girls: trend from 2008 to 2012. Vaccine. 2015 Jan 29; 33(5):585-7.
    View in: PubMed
    Score: 0.109
  30. Effect of the decision-making process in the family on HPV vaccination rates among adolescents 9-17 years of age. Hum Vaccin Immunother. 2014; 10(7):1807-11.
    View in: PubMed
    Score: 0.102
  31. Knowledge of human papillomavirus among dental providers: A mixed methods study. Vaccine. 2020 01 16; 38(3):423-426.
    View in: PubMed
    Score: 0.038
  32. Change in Human Papillomavirus Prevalence Among U.S. Women Aged 18-59 Years, 2009-2014. Obstet Gynecol. 2017 10; 130(4):693-701.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.